Advisory Services Network, LLC Cel Sci Corp Transaction History

Advisory Services Network, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$1.07 - $3.07 $321 - $921	300 New	300 $0
Q4 2022 Feb 13, 2023	BUY	$1.99 - $3.52 $597 - $1,056	300 New	300 $0
Q3 2021 Nov 05, 2021	SELL	$7.64 - $12.49 $38,964 - $63,699	-5,100 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$8.68 - $27.49 $44,268 - $140,199	5,100 New	5,100 $44,000
Q1 2021 May 24, 2021	SELL	$12.0 - $27.64 $3,600 - $8,292	-300 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$11.69 - $14.54 $3,507 - $4,362	300 New	300 $4,000
Q2 2020 Aug 10, 2020	SELL	$9.75 - $17.6 $2,925 - $5,280	-300 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$7.54 - $17.05 $2,262 - $5,115	300 New	300 $3,000

27.1K

150K

Ticker CVM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,367,500
Market Cap $26.9M
Description
CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.